The Nobel Biocare share
Share information
| Listing |
|
SIX Swiss Exchange |
| Security number |
|
003785164 |
| ISIN number |
|
CH0037851646 |
| Reuters |
|
NOBN.VX |
| Bloomberg |
|
NOBN VX |
|---|
Further capital and share-related information may be found in the Corporate Governance section.
Dividend policy and proposal
Nobel Biocare’s dividend policy is based on the capital management principles as outlined here and should reflect the Group’s long-term financial development, taking into account the need for investments and the expected economic fluctuations in particular years. It is designed to maintain attractive dividend yields for investors and an affordable payout ratio of between 35 percent and 45 percent (calculated as dividend in percentage of available profit for the year) as a general target.
For 2011, the Board of Directors proposes a dividend of CHF 0.15 (2010: CHF 0.35). The proposed dividend for the 2011 financial year is equivalent to 38 percent of profit after tax (2010: 75 percent).
Share trends and turnover
| | | 2011 | | 2010 |
| | | | | |
| Share price at year-end |
|
CHF 10.92 |
|
CHF 17.63 |
| Market value |
|
CHF 1'352 mn |
|
CHF 2'182 mn |
| Variance |
|
–38.1% |
|
–49.3% |
| All-year high |
|
CHF 20.78 |
|
CHF 36.15 |
| Date |
|
16 Feb 2011 |
|
04 Jan 2010 |
| All-year low |
|
CHF 7.76 |
|
CHF 15.20 |
| Date |
|
23 Sep 2011 |
|
03 Nov 2010 |
| Trading volume (shares) |
|
293.0 mn |
|
303.0 mn |
| Average per day |
|
1'153'724 |
|
1'192'882 |
|---|
The analysts listed here follow the Nobel Biocare share. Please note that any opinions, estimates or forecasts regarding Nobel Biocare’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Nobel Biocare or its management. Nobel Biocare does not by its reference above imply its endorsement of or concurrence with such information, conclusions or recommendations.
Share data1
| | | 2011 | | 2010 | | 2009 | | 2008 | | 2007 | | 2006 |
| Shares on 31 December |
(number) |
123'784'530 |
|
123'784'530 |
|
123'784'530 |
|
124'316'530 |
|
132'828'970 |
|
131'496'125 |
| Average number of shares |
(number) |
122'775'158 |
|
123'035'900 |
|
123'276'298 |
|
122'269'517 |
|
123'439'020 |
|
124'789'750 |
| Shares after full conversion 2 |
(number) |
149'032'150 |
|
149'032'150 |
|
149'032'620 |
|
124'564'150 |
|
133'086'590 |
|
133'086'590 |
| Share price 31 December |
(CHF) |
10.92 |
|
17.63 |
|
34.78 |
|
21.42 |
|
60.60 |
|
72.05 |
| Market value 31 December |
(CHF mn) |
1'352 |
|
2'182 |
|
4'305 |
|
2'663 |
|
8'049 |
|
9'474 |
| Dividend per share 3 |
(CHF) |
0.15 |
|
0.35 |
|
0.55 |
|
0.55 |
|
0.95 |
|
0.85 |
| Yield 3 |
(%) |
1.37 |
|
1.99 |
|
1.58 |
|
2.57 |
|
1.57 |
|
1.18 |
| Dividend percentage 3 |
(%) |
38 |
|
75 |
|
43 |
|
41 |
|
46 |
|
45 |
| Basic earnings per share |
(EUR) |
0.32 |
|
0.37 |
|
0.86 |
|
0.90 |
|
1.35 |
|
1.27 |
| Diluted earnings per share |
(EUR) |
0.32 |
|
0.37 |
|
0.85 |
|
0.90 |
|
1.34 |
|
1.26 |
| Equity per share |
(EUR) |
2.27 |
|
2.59 |
|
2.58 |
|
2.19 |
|
2.17 |
|
2.89 |
| Equity per share after full conversion |
(EUR) |
1.89 |
|
2.15 |
|
2.13 |
|
2.15 |
|
2.01 |
|
2.71 |
| Cash flow from operations per share |
(EUR) |
0.76 |
|
0.79 |
|
1.44 |
|
1.38 |
|
1.09 |
|
1.28 |
| P/E ratio after tax |
|
27 |
|
34 |
|
27 |
|
16 |
|
27 |
|
35 |
|---|